相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Opportunities and challenges in leveraging electronic health record data in oncology
Marc L. Berger et al.
FUTURE ONCOLOGY (2016)
Real-world chemotherapy treatment patterns in metastatic non-small cell lung cancer: Are patients undertreated?
Adrian G. Sacher et al.
CANCER (2015)
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Gregory A. Masters et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The 2015 World Health Organization Classification of Lung Tumors Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Non-small cell lung cancer patients with brain metastases treated with first-line platinum-doublet chemotherapy: Analysis from the European FRAME study
Denis Moro-Sibilot et al.
LUNG CANCER (2015)
Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer
Keith L. Davis et al.
LUNG CANCER (2015)
2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease
B. Besse et al.
ANNALS OF ONCOLOGY (2014)
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M. Reck et al.
ANNALS OF ONCOLOGY (2014)
Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patients
Niels Reinmuth et al.
RESPIRATORY RESEARCH (2013)
Treatment patterns and healthcare costs among patients with advanced non-small-cell lung cancer
Henry J. Henk et al.
LUNG CANCER MANAGEMENT (2013)
Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapy
B. Coudert et al.
ANNALS OF ONCOLOGY (2012)
First-Line Systemic Therapy Practice Patterns and Concordance With NCCN Guidelines for Patients Diagnosed With Metastatic NSCLC Treated at NCCN Institutions
Carrie Zornosa et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)
Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial
Luis Paz-Ares et al.
LANCET ONCOLOGY (2012)
Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the cancer research network
Debra P. Ritzwoller et al.
LUNG CANCER (2012)
Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study
Federico Cappuzzo et al.
LANCET ONCOLOGY (2010)
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study
Tudor Ciuleanu et al.
LANCET (2009)
Trends and predictors of first-line chemotherapy use among elderly patients with advanced non-small cell lung cancer in the United States
Kathleen Lang et al.
LUNG CANCER (2009)
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
Giorgio Vittorio Scagliotti et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Molecular origins of cancer: Lung cancer
Roy S. Herbst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
分享论文
